The new mission
"We use each person's data to add healthy years to their life — for the sickest and the healthiest alike."
The vision
A community where biological age falls below chronological age, because health is produced daily — not repaired annually — and the same engine serves the Medi-Cal diabetic and the cash-pay executive.
The Age Gap (headline)
mean(chronological − biological age), DunedinPACE — a widening negative gap on the engaged cohort. Population-level only, never billed.
MLR & total cost of care
the board-facing number the plan is actually graded on — the only one that reaches the margin.
Controlled chronic disease
A1c<8, BP<140/90 across the burden — the reimbursable intermediates prevention truly moves.
Avoidable ED & admits /1,000
the internalized-Part-A lever (CenterWell benchmark: >30% fewer stays in seniors).
12-mo retention & MAU
the binding constraint — biology only bends at sustained dose, and gyms lose ~30%/yr.
Aligned lives at risk
shared-savings → global-risk → plan — the physician-supply gate that governs scale.
The verdict, up front
1Your vision survives — re-sequenced
All three investment-committee lenses rated it viable (Financial 64 · Market/Science 66 · Regulatory/Execution 62). But the panel moved the pieces — and the most important finding is counterintuitive.
What's right — and it's the whole point
A prevention-first, data-centered payvider that serves both the sickest and the healthiest from one engine is the correct destination. The biological-age North Star is a genuinely differentiated, sticky consumer brand. And the model maps one-to-one onto the "Tesla stack" the last engagement already found — this is that stack wearing a consumer skin.
What the panel moved — the hard truth
Three of the four pieces you're most excited about — the gym, the labs, the biological-age clock — are copyable, commoditizing, low-margin front doors. They must be booked at ~$0 net. They're the cheapest way to drive the behavior, not profit centers. The margin comes from a fourth piece: owning the risk on aligned lives so a prevented admission becomes retained premium against beds RCH owns at ~50¢.
The re-sequencing (this is the strategy)
ALIGN the provider group, don't buy it (PHN's ~54k lives; CPOM-compliant MSO). Own the plan LAST — go at-risk under a partner's Knox-Keene license first, so the reserves sit on their balance sheet, not RCH's. The gym is one clinically-integrated studio, not a chain. The clock motivates; the reimbursable biomarkers (A1c, BP, lipids, weight) and the internalized-Part-A economics do the earning.
The model
2Five layers — and where each actually earns
Honesty by layer: what it is, and its real net margin. The consumer layers are the front door; the plan + provider group are the engine.
Provider group
Align, don't buy. PHN IPA (~600 providers / ~54k lives) as the risk anchor + CAMG, RYMG, Maren for corridor primary care + Arrowhead Ortho for co-management. Friendly-PC / MSO (CPOM-compliant); SB351 makes RCH the only non-payer, non-PE aggregator.
MSO 15–20%
The plan
Staged Knox-Keene, risk-laddered. Shared-savings → global-risk under a partner license → own plan only after the prevention thesis is proven. The underwriting margin is a capture wrapper, not the profit center.
2–4% wrapper
Part A ~50¢
Part A ~50¢
The gym
ONE clinically-integrated medical-fitness studio (Power Wellness-class outsourced ops), anchored on a reimbursable Diabetes Prevention Program. The daily touchpoint healthcare never has — and a fitness operating business, not a tech multiple.
~0% net
(front door)
(front door)
Labs + longevity clinic
DTC bio-age testing + a cash-pay longevity clinic (Life Time MIORA blueprint) for the affluent 92373 pocket. High gross margin, but a commoditizing category (Function $499→$365). A funnel that generates data + a modest clinic line.
DTC ~0% net
clinic ~10–15%
clinic ~10–15%
The AI / data spine
FHIR spine (EHR + claims + labs + wearables) + patient AI overlay + population-health engine + physician unified-data view. A cost center whose value is realized as MLR reduction and retention — the demand-side complement to RedlandsOS's supply-side cost engine.
enabler
(neg run-rate)
(neg run-rate)
The honest bridge
3Where the money actually is — and isn't
From the −$16M baseline. The consumer lines you love are ~$0 net; the earning is internalized Part A on aligned risk lives. All planning estimates.
| Lever | $M/yr | Timing | Basis |
|---|---|---|---|
| Internalized Part A on aligned senior-risk lives | +11.0 | FY31–34 | ~15,000 MA-equiv aligned lives via PHN × ~$15.7k premium ≈ $235M; avoided admissions retained against owned beds at ~50¢ |
| MSO management fees | +1.5 | FY30–32 | ~150 aligned providers, Privia-class 15–20% take-rate |
| Cash-pay longevity clinic (MIORA) | +1.2 | FY30–33 | ~800–1,200 members × ~$1,800–3,000/yr |
| Medicare DPP reimbursement | +0.3 | FY29–31 | ~1,500–2,000 completers × up to $822; largely offset by coaching |
| Gym / medical-fitness contribution | +0.0 | FY29 on | booked at zero — the engagement front door, not a profit center |
| Bio-age / DTC lab testing | +0.0 | FY29 on | high gross, ~0% net after CAC in a price-collapsing category — a funnel |
| New: plan reserves / TPA / actuarial / care-mgmt | −4.0 | FY28 on | Knox-Keene TNE + the care-management build (peaks in the J-curve) |
| New: AI / data platform run-rate | −2.5 | FY28 on | compute, integration, cyber, AI governance |
| New: medical-fitness studio opex drag | −1.0 | FY28–31 | pre-scale fixed cost of the single studio + outsourced management |
FY2029–30
break-even — carried by the RedlandsOS cost engine (ops), not by Strategy 6's new lines
+$10–14M
realistic steady state by FY34 (if the FY30 senior-risk gate fires, ~40–50%)
+$20M
option value only — needs the senior-risk book past ~25k at-risk lives + a second engine
~$45–60M
external capital, staged & gated — partner holds the plan reserves; RCH funds nothing
Why +$20M can't come from "owning the plan" — say it plainly
A health plan nets 2–4% of premium at maturity (and >70% of MA plans are now break-even-or-below; the MA segment posted ~−$2.9B underwriting in 2024). At a top-decile 3% net you'd need ~$667M of premium — ~42,500 MA lives. RCH's entire capturable commercial pool is ~22,000 lives (1,405 on the plan today). Building 42,500 MA lives on one 211-bed hospital with 36.8% share this decade is implausible. The plan is a margin-capture wrapper; the earning is internalized Part A. Anyone modeling +$20M off "3% of a big premium" or off gym/lab/clock subscriptions is fantasizing.
The North Star, honestly
4Biological age — what the science does & doesn't support
Usable (population signal)
DunedinPACE is the best-validated pace-of-aging clock (65+ cohorts, 300+ papers, ICC ~0.96 on the corrected version); GrimAge is the strongest mortality predictor. A slower pace is robustly associated at cohort level with lower heart-disease, stroke, disability and dementia risk. The one randomized causal signal — the CALERIE RCT — shows lifestyle can slow DunedinPACE ~2–3% over two years. Real, but small.
Forbidden claims (guardrails)
No individual "we reversed your age" — a single retest often sits inside the ~9-year technical-noise band; bio-age is honest only as a cohort/engagement signal. No "lowering your clock lowers your cost/mortality" — causation unproven. No billing, risk-adjustment, or care-authorization use — no payer/CMS credits it, and RCH would be a licensee of DunedinPACE (TruDiagnostic), owning no aging IP.
Operating rules
Run bio-age as a CLIA wellness/informational test, framed as wellness — never diagnostic. Pick one clock (DunedinPACE, PC-corrected) and never mix clocks. Pair every consumer age-gap with the reimbursable biomarkers that drive the MLR math (A1c, lipids, BP, weight). Route any true lab abnormality to a licensed (non-RCH-employed, CPOM-compliant) physician. Keep marketing clear of clinical/FTC over-claim. The clock is the differentiated brand that makes the front door sticky; it is never the clinical or financial engine.
The moat & the portfolio
5Why it pulls away — and how it fits the five
Not the gym/labs/clock
Those fail the copy test cold — a 3–5-club chain is Optum/Kaiser pocket change; Life Time MIORA (180+ sites) and Equinox+Function already own the longevity brand; Function shipped the unified data+AI platform in 2025 at $2.5B; DunedinPACE is licensed, not owned.
Internalized Part A
RCH owns hospital days at ~50¢ marginal cost with 56.6% occupancy headroom — so a prevented admission becomes retained premium, not lost revenue. This is the structural economics Oak Street / Cano / CareMax all lacked, and no consumer-longevity brand or pure-play VBC can replicate without buying a hospital.
SB351-clean aggregation + owned data
RCH is the only non-PE, non-payer entity legally able to consolidate the 188 independent groups — and CAMG (built to rebuild independence), RYMG (fled Optum), and PHN (whose feared alternative is Optum) align with RCH because they distrust the copycats. Plus longitudinal resident data no pure-play holds.
Count it once — it's the Tesla stack wearing a consumer skin
Strategy 6 extends the five-strategy portfolio; it doesn't add to it. Its plan + PHN-alignment + internalized-Part-A line IS the portfolio's senior-risk engine (Strategy 3's PHN lever + Strategy 4's internalized-Part-A insight) — the +$11M is that same gated engine, not a new dollar. Its AI/data spine is the demand-side complement to RedlandsOS's supply-side cost engine: RedlandsOS takes cost out of the building; the population-health engine keeps people out of it. The gym + clock are the consumer front end that finally fixes the stack's weakest link — patient engagement.
How to start
6Capital, and the first 12 months
~$45–60M external, staged & gated — RCH funds nothing
- A partner health plan / capitated JV absorbs the 3–5-yr underwriting J-curve first — RCH goes at-risk under their Restricted Knox-Keene paper (~$20–25M of reserves on the partner's balance sheet). Why they say yes: RCH brings the SB351-clean alliance + owned beds no pure-play can assemble here.
- Anchor-employer direct contracts (ESRI ~4,890 self-funded lives, RUSD, 12 in-city self-funded employers) pre-commit lives — killing the adverse-selection spiral that sank past provider plans.
- Philanthropy ~$8–12M — "the first community health-production system in America" funds the data spine + studio (both map to the mandatory community-benefit plan).
- Sponsor equity ~$10–15M into an MSO+data NewCo (RCH contributes playbook IP for founder equity).
- Gym financing ~$4–7M on the single studio — cheap, non-strategic, not worth balance-sheet cash.
First 12 months
- Q1 — Seat the new-CEO-sponsored steering group; commission CA counsel on friendly-PC+MSO vs. §1206(l) and the AG/OHCA path.
- Q1–Q2 — Secure the partner plan / capitated JV to hold the J-curve; open the philanthropy campaign.
- Q2 — First five hires + friendly-PC/MSO stand-up; DMHC network-adequacy modeling against PHN density.
- Q2–Q3 — Stand up the FHIR data spine + ship the physician unified-data view; publish the AI-governance framework.
- Q3 — Front door live as a reimbursed MDPP program (not a membership); the one medical-fitness studio opens.
- Q4 — Sign the first shared-savings / global-risk arrangement on aligned lives under the partner's license; launch the cash-pay longevity clinic.
← The five verified strategies · The 188 independents (align, don't buy) · Read the full Strategy 6 →
Method & honesty. Developed in two framings (full integrated build vs. capital-light staged) grounded in web research on gym/medical-fitness economics, the epigenetic-aging literature (Horvath/GrimAge/PhenoAge/DunedinPACE + the CALERIE RCT), and provider-sponsored-plan history; stress-tested by a financial-realism, market/competitive+science, and regulatory/execution panel (all three rated the staged framing viable). Biological-age clocks are validated population predictors, not diagnostics or reimbursable tests, and are used here only as engagement/North-Star metrics at cohort level. Planning estimates throughout — not medical, actuarial, legal, or investment advice. Baseline: client-stated −$16M/yr.